                               SEQUENCE LISTING

<110> THE GENERAL HOSPITAL CORPORATION
 
<120> COMPOSITIONS AND METHODS FOR TREATING ALLERGIC INFLAMMATION

<130> 030258-083181-PCT

<140> PCT/US2016/020905
<141> 2016-03-04

<150> 62/129,228
<151> 2015-03-06

<160> 16    

<170> PatentIn version 3.5

<210> 1
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide 


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid except proline

<400> 1
Asn Xaa Ser 
1           


<210> 2
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide 


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid except proline

<400> 2
Asn Xaa Thr 
1           


<210> 3
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide 


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid except proline

<400> 3
Asn Xaa Cys 
1           


<210> 4

<400> 4
000


<210> 5

<400> 5
000


<210> 6

<400> 6
000


<210> 7

<400> 7
000


<210> 8

<400> 8
000


<210> 9

<400> 9
000


<210> 10

<400> 10
000


<210> 11

<400> 11
000


<210> 12

<400> 12
000


<210> 13

<400> 13
000


<210> 14

<400> 14
000


<210> 15

<400> 15
000


<210> 16
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic 
      peptide 


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Ser or Thr

<400> 16
Asn Xaa Xaa 
1           


